DaVita Inc. (0I7E.L)
USD 140.53
(-0.62%)
USD 140.53
(-0.62%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 10.65 Billion USD | -8.0% |
| 2022 | 11.57 Billion USD | 0.57% |
| 2021 | 11.51 Billion USD | 5.93% |
| 2020 | 10.86 Billion USD | 7.9% |
| 2019 | 10.07 Billion USD | 3.01% |
| 2018 | 9.77 Billion USD | 10.77% |
| 2017 | 8.82 Billion USD | 7.67% |
| 2016 | 8.19 Billion USD | 7.44% |
| 2015 | 7.63 Billion USD | 1.23% |
| 2014 | 7.53 Billion USD | 0.92% |
| 2013 | 7.46 Billion USD | -6.87% |
| 2012 | 8.02 Billion USD | 95.09% |
| 2011 | 4.11 Billion USD | 18.34% |
| 2010 | 3.47 Billion USD | 11.22% |
| 2009 | 3.12 Billion USD | -4.9% |
| 2008 | 3.28 Billion USD | 0.74% |
| 2007 | 3.26 Billion USD | -5.25% |
| 2006 | 3.44 Billion USD | -7.63% |
| 2005 | 3.72 Billion USD | 231.48% |
| 2004 | 1.12 Billion USD | 1.62% |
| 2003 | 1.1 Billion USD | -9.56% |
| 2002 | 1.22 Billion USD | 56.06% |
| 2001 | 783.51 Million USD | -17.04% |
| 2000 | 944.47 Million USD | 1347.66% |
| 1999 | -75.7 Million USD | -106.28% |
| 1998 | 1.2 Billion USD | 241.48% |
| 1997 | 353.2 Million USD | 316.51% |
| 1996 | 84.8 Million USD | 229.96% |
| 1995 | 25.7 Million USD | -70.15% |
| 1994 | 86.1 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 11.17 Billion USD | -2.82% |
| 2024 Q3 | 8.48 Billion USD | -0.4% |
| 2024 Q1 | 11.49 Billion USD | 7.93% |
| 2023 Q4 | 10.65 Billion USD | -0.26% |
| 2023 FY | 10.65 Billion USD | -8.0% |
| 2023 Q2 | 11.15 Billion USD | -0.37% |
| 2023 Q1 | 11.19 Billion USD | -3.33% |
| 2023 Q3 | 10.67 Billion USD | -4.22% |
| 2022 Q3 | 11.66 Billion USD | -2.79% |
| 2022 Q4 | 11.57 Billion USD | -0.78% |
| 2022 FY | 11.57 Billion USD | 0.57% |
| 2022 Q1 | 11.56 Billion USD | 0.46% |
| 2022 Q2 | 12 Billion USD | 3.78% |
| 2021 Q4 | 11.51 Billion USD | 4.7% |
| 2021 FY | 11.51 Billion USD | 5.93% |
| 2021 Q1 | 11.22 Billion USD | 3.28% |
| 2021 Q2 | 11.04 Billion USD | -1.58% |
| 2021 Q3 | 10.99 Billion USD | -0.47% |
| 2020 Q2 | 9.94 Billion USD | -3.45% |
| 2020 Q1 | 10.29 Billion USD | 2.22% |
| 2020 Q3 | 10.39 Billion USD | 4.56% |
| 2020 Q4 | 10.86 Billion USD | 4.55% |
| 2020 FY | 10.86 Billion USD | 7.9% |
| 2019 Q2 | 8.45 Billion USD | -34.95% |
| 2019 Q1 | 12.99 Billion USD | 32.91% |
| 2019 Q3 | 9.93 Billion USD | 17.55% |
| 2019 Q4 | 10.07 Billion USD | 1.35% |
| 2019 FY | 10.07 Billion USD | 3.01% |
| 2018 Q1 | 9.1 Billion USD | 3.14% |
| 2018 FY | 9.77 Billion USD | 10.77% |
| 2018 Q4 | 9.77 Billion USD | 0.03% |
| 2018 Q3 | 9.77 Billion USD | 2.32% |
| 2018 Q2 | 9.55 Billion USD | 4.94% |
| 2017 Q4 | 8.82 Billion USD | 6.97% |
| 2017 FY | 8.82 Billion USD | 7.67% |
| 2017 Q1 | 7.61 Billion USD | -7.1% |
| 2017 Q2 | 8.38 Billion USD | 10.03% |
| 2017 Q3 | 8.25 Billion USD | -1.54% |
| 2016 FY | 8.19 Billion USD | 7.44% |
| 2016 Q4 | 8.19 Billion USD | -0.15% |
| 2016 Q3 | 8.21 Billion USD | 5.03% |
| 2016 Q2 | 7.81 Billion USD | -3.2% |
| 2016 Q1 | 8.07 Billion USD | 5.83% |
| 2015 FY | 7.63 Billion USD | 1.23% |
| 2015 Q1 | 7.48 Billion USD | -0.68% |
| 2015 Q3 | 8.14 Billion USD | -1.53% |
| 2015 Q4 | 7.63 Billion USD | -6.36% |
| 2015 Q2 | 8.27 Billion USD | 10.54% |
| 2014 Q3 | 6.97 Billion USD | -5.46% |
| 2014 FY | 7.53 Billion USD | 0.92% |
| 2014 Q2 | 7.37 Billion USD | 1.69% |
| 2014 Q1 | 7.25 Billion USD | -2.86% |
| 2014 Q4 | 7.53 Billion USD | 8.07% |
| 2013 Q2 | 7.85 Billion USD | 0.68% |
| 2013 Q4 | 7.46 Billion USD | -0.01% |
| 2013 FY | 7.46 Billion USD | -6.87% |
| 2013 Q3 | 7.47 Billion USD | -4.94% |
| 2013 Q1 | 7.8 Billion USD | -2.68% |
| 2012 Q3 | 5.35 Billion USD | 26.78% |
| 2012 Q1 | 4.04 Billion USD | -1.68% |
| 2012 FY | 8.02 Billion USD | 95.09% |
| 2012 Q4 | 8.02 Billion USD | 49.74% |
| 2012 Q2 | 4.22 Billion USD | 4.52% |
| 2011 FY | 4.11 Billion USD | 18.34% |
| 2011 Q4 | 4.11 Billion USD | 3.85% |
| 2011 Q3 | 3.95 Billion USD | 11.32% |
| 2011 Q2 | 3.55 Billion USD | 7.42% |
| 2011 Q1 | 3.31 Billion USD | -4.0% |
| 2010 Q2 | 2.83 Billion USD | -1.55% |
| 2010 Q1 | 2.88 Billion USD | -7.73% |
| 2010 Q3 | 2.85 Billion USD | 0.6% |
| 2010 Q4 | 3.44 Billion USD | 20.81% |
| 2010 FY | 3.47 Billion USD | 11.22% |
| 2009 Q4 | 3.12 Billion USD | 0.53% |
| 2009 Q1 | 3.31 Billion USD | 0.86% |
| 2009 Q2 | 3.12 Billion USD | -5.58% |
| 2009 Q3 | 3.1 Billion USD | -0.66% |
| 2009 FY | 3.12 Billion USD | -4.9% |
| 2008 FY | 3.28 Billion USD | 0.74% |
| 2008 Q1 | 3.22 Billion USD | -1.05% |
| 2008 Q2 | 3.38 Billion USD | 4.84% |
| 2008 Q3 | 3.31 Billion USD | -1.85% |
| 2008 Q4 | 3.28 Billion USD | -1.06% |
| 2007 FY | 3.26 Billion USD | -5.25% |
| 2007 Q4 | 3.26 Billion USD | -1.62% |
| 2007 Q1 | 3.39 Billion USD | -1.22% |
| 2007 Q2 | 3.31 Billion USD | -2.59% |
| 2007 Q3 | 3.31 Billion USD | 0.09% |
| 2006 Q4 | 3.44 Billion USD | -3.46% |
| 2006 Q3 | 3.56 Billion USD | -1.12% |
| 2006 Q2 | 3.6 Billion USD | -4.27% |
| 2006 Q1 | 3.76 Billion USD | 1.07% |
| 2006 FY | 3.44 Billion USD | -7.63% |
| 2005 Q4 | 3.72 Billion USD | 262.46% |
| 2005 Q3 | 1.02 Billion USD | -2.4% |
| 2005 FY | 3.72 Billion USD | 231.48% |
| 2005 Q2 | 1.05 Billion USD | 0.25% |
| 2005 Q1 | 1.05 Billion USD | -6.53% |
| 2004 Q3 | 1.16 Billion USD | 23.07% |
| 2004 FY | 1.12 Billion USD | 1.62% |
| 2004 Q1 | 1 Billion USD | -9.38% |
| 2004 Q4 | 1.12 Billion USD | -3.2% |
| 2004 Q2 | 943.41 Million USD | -5.86% |
| 2003 FY | 1.1 Billion USD | -9.56% |
| 2003 Q4 | 1.1 Billion USD | 5.25% |
| 2003 Q3 | 1.05 Billion USD | -7.94% |
| 2003 Q2 | 1.14 Billion USD | -1.56% |
| 2003 Q1 | 1.15 Billion USD | -5.17% |
| 2002 Q3 | 1.2 Billion USD | 1.62% |
| 2002 Q4 | 1.22 Billion USD | 1.33% |
| 2002 Q2 | 1.18 Billion USD | 54.49% |
| 2002 Q1 | 768.6 Million USD | -1.9% |
| 2002 FY | 1.22 Billion USD | 56.06% |
| 2001 Q4 | 783.51 Million USD | 1.08% |
| 2001 FY | 783.51 Million USD | -17.04% |
| 2001 Q3 | 775.15 Million USD | -10.43% |
| 2001 Q1 | 922.16 Million USD | -2.36% |
| 2001 Q2 | 865.4 Million USD | -6.15% |
| 2000 Q1 | -121.44 Million USD | -60.43% |
| 2000 Q3 | 1.04 Billion USD | -6.68% |
| 2000 Q4 | 944.47 Million USD | -9.53% |
| 2000 Q2 | 1.11 Billion USD | 1021.15% |
| 2000 FY | 944.47 Million USD | 1347.66% |
| 1999 Q1 | 1.3 Billion USD | 8.14% |
| 1999 Q4 | -75.7 Million USD | -105.46% |
| 1999 Q3 | 1.38 Billion USD | -1.48% |
| 1999 FY | -75.7 Million USD | -106.28% |
| 1999 Q2 | 1.4 Billion USD | 7.95% |
| 1998 Q4 | 1.2 Billion USD | 7.94% |
| 1998 Q1 | 872.3 Million USD | 146.97% |
| 1998 Q3 | 1.11 Billion USD | 6.46% |
| 1998 FY | 1.2 Billion USD | 241.48% |
| 1998 Q2 | 1.04 Billion USD | 20.33% |
| 1997 Q1 | 95.4 Million USD | 12.5% |
| 1997 Q2 | 186.1 Million USD | 95.07% |
| 1997 Q3 | 238.4 Million USD | 28.1% |
| 1997 Q4 | 353.2 Million USD | 48.15% |
| 1997 FY | 353.2 Million USD | 316.51% |
| 1996 FY | 84.8 Million USD | 229.96% |
| 1996 Q4 | 84.8 Million USD | 15.22% |
| 1996 Q2 | 19.1 Million USD | -80.35% |
| 1996 Q1 | 97.2 Million USD | 634.07% |
| 1996 Q3 | 73.6 Million USD | 285.34% |
| 1995 Q2 | 86.1 Million USD | 0.0% |
| 1995 Q3 | 99.8 Million USD | 15.91% |
| 1995 FY | 25.7 Million USD | -70.15% |
| 1995 Q4 | -18.2 Million USD | -118.24% |
| 1994 FY | 86.1 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Phreesia, Inc. | -75.53 Million USD | 14201.417% |
| Accuray Incorporated | 103.58 Million USD | -10183.037% |
| Align Technology, Inc. | -840.47 Million USD | 1367.361% |
| Elevance Health Inc. | 18.59 Billion USD | 42.714% |
| AxoGen, Inc. | 32.26 Million USD | -32912.419% |
| Boston Scientific Corporation | 8.23 Billion USD | -29.395% |
| CVS Health Corporation | 71.18 Billion USD | 85.037% |
| Cardinal Health, Inc. | 476 Million USD | -2137.77% |
| Centene Corporation | 506 Million USD | -2005.096% |
| HCA Healthcare, Inc. | 40.92 Billion USD | 73.972% |
| Hologic, Inc. | 374.4 Million USD | -2745.029% |
| Humana Inc. | 5.51 Billion USD | -93.002% |
| IDEXX Laboratories, Inc. | 493.94 Million USD | -2056.459% |
| Laboratory Corporation of America Holdings | 5.41 Billion USD | -96.622% |
| Masimo Corporation | 804 Million USD | -1224.849% |
| McKesson Corporation | 889 Million USD | -1098.176% |
| Patterson Companies, Inc. | 648.47 Million USD | -1542.583% |
| Quest Diagnostics Incorporated | 4.68 Billion USD | -127.456% |
| ResMed Inc. | 635.57 Million USD | -1575.932% |
| Henry Schein, Inc. | 2.57 Billion USD | -314.466% |
| Teladoc Health, Inc. | 468.6 Million USD | -2173.099% |
| Universal Health Services, Inc. | 5.24 Billion USD | -103.0% |
| Veeva Systems Inc. | -647.71 Million USD | 1744.525% |
| Baxter International Inc. | 11.16 Billion USD | 4.605% |
| Becton, Dickinson and Company | 14.46 Billion USD | 26.351% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 500.398% |
| Danaher Corporation | 13.49 Billion USD | 21.051% |
| Stryker Corporation | 10.02 Billion USD | -6.263% |
| Medtronic plc | 23.67 Billion USD | 55.016% |